Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin
FD Richard HobbsUniversity of Birmingham, Edgbaston, Birmingham B15 2TT, UK.Abstract: In order to prevent cardiovascular events, it is essential to effectively manage overall risk of cardiovascular disease. However, despite guideline recommendations to this effect, current management of the major, m...
Main Author: | FD Richard Hobbs |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2007-11-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/can-combining-different-risk-interventions-into-a-single-formulation-c-peer-reviewed-article-VHRM |
Similar Items
-
Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
by: Bimal V Patel, et al.
Published: (2008-06-01) -
Efficacy and Safety of a Single-Pill Combination of Atorvastatin/Amlodipine
in Patients with Arterial Hypertension and Dyslipidemia
by: Stefan Naydenov Naydenov, et al.
Published: (2018-01-01) -
Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)
by: Ji-Hyun Park, et al.
Published: (2015-02-01) -
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
by: Madhuri Devabhaktuni, et al.
Published: (2009-04-01) -
Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial
by: Richard Grimm, et al.
Published: (2010-04-01)